Literature DB >> 7924014

Gestation in women with kidney disease: prognosis and management.

M D Lindheimer1, A I Katz.   

Abstract

Physicians may be called upon to guide patients with renal disease on the advisability of conceiving or maintaining a gestation, or to manage pregnancies permitted to continue. The prevailing view is that the degree of functional impairment and the presence or absence of hypertension prior to conception determine both pregnancy outcome and the effect of gestation on the natural history of the kidney disorder (Table 3). Normotensive women with minimal dysfunction have a greater than 90% chance of success and there is little evidence that gestation will adversely affect the disease. Presence of hypertension increases the complications rate substantially if not aggressively controlled, and prognosis is also poorer in women with moderate renal dysfunction. Most gestations in the latter group succeed, but at considerable maternal risk: over 20% of these women experience renal functional deterioration, and 30-40% of them have major problems with hypertension. Thus we tend not to recommend pregnancy in patients with moderate renal insufficiency, and definitely discourage gestation when GFR is severely impaired. We advise termination, as most of these gestations fail, and maternal risk is substantial. There are a number of diseases in which pregnancy should not be undertaken, including scleroderma and periarteritis. Some authors believe that women with membranoproliferative glomerulonephritis also do poorly, and opinions differ on the effects of gestation on IgA nephropathy, focal glomerulosclerosis, and reflux nephropathy. Table 4 summarizes our view concerning pregnancy in a number of specific renal disorders. Finally, in addition to the controversies noted above, there are other unresolved problems requiring further study. For instance, protein restriction should be avoided until the effect of this therapeutic manoeuvre on fetal development is evaluated. Also needed are conclusive studies on whether or not the physiological hyperfiltration of human pregnancy affects adversely pre-existing renal disease.

Entities:  

Mesh:

Year:  1994        PMID: 7924014     DOI: 10.1016/s0950-3552(05)80327-x

Source DB:  PubMed          Journal:  Baillieres Clin Obstet Gynaecol        ISSN: 0950-3552


  6 in total

1.  Microvascular complications and the diabetic pregnancy.

Authors:  Melton J Bond; Jason G Umans
Journal:  Curr Diab Rep       Date:  2006-08       Impact factor: 4.810

Review 2.  Pregnancy and renal failure: the case for application of dosage guidelines.

Authors:  F Keller; M Griesshammer; U Häussler; W Paulus; A Schwarz
Journal:  Drugs       Date:  2001       Impact factor: 9.546

3.  Pregnancy in women with renal disease. Yes or no?

Authors:  K Edipidis
Journal:  Hippokratia       Date:  2011-01       Impact factor: 0.471

4.  Risk of Adverse Pregnancy Outcomes in Women with CKD.

Authors:  Giorgina Barbara Piccoli; Gianfranca Cabiddu; Rossella Attini; Federica Neve Vigotti; Stefania Maxia; Nicola Lepori; Milena Tuveri; Marco Massidda; Cecilia Marchi; Silvia Mura; Alessandra Coscia; Marilisa Biolcati; Pietro Gaglioti; Michele Nichelatti; Luciana Pibiri; Giuseppe Chessa; Antonello Pani; Tullia Todros
Journal:  J Am Soc Nephrol       Date:  2015-03-12       Impact factor: 10.121

5.  Membranous nephropathy associated with pregnancy: an anti-phospholipase A2 receptor antibody-positive case report.

Authors:  Eiichiro Uchino; Daisuke Takada; Haruta Mogami; Takeshi Matsubara; Tatsuo Tsukamoto; Motoko Yanagita
Journal:  CEN Case Rep       Date:  2018-01-18

6.  Management of Membranous Glomerulonephritis in Pregnancy: A Multidisciplinary Challenge.

Authors:  Sherifat Ope-Adenuga; Michael Moretti; Nisha Lakhi
Journal:  Case Rep Obstet Gynecol       Date:  2015-12-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.